Pfizer Appoints New Chief Science Officer, Boosting Leadership in Oncology

Pfizer, one of the world’s leading biopharmaceutical companies, has announced a significant leadership change by appointing Dr. Angela Boshoff as its new Chief Science Officer (CSO). This move is notable, coming on the heels of her previous role leading the oncology division within the company, where she was instrumental in advancing Pfizer’s portfolio of cancer therapies.

Continue reading